Literature DB >> 27540827

Nuclear physics in particle therapy: a review.

Marco Durante1, Harald Paganetti.   

Abstract

Charged particle therapy has been largely driven and influenced by nuclear physics. The increase in energy deposition density along the ion path in the body allows reducing the dose to normal tissues during radiotherapy compared to photons. Clinical results of particle therapy support the physical rationale for this treatment, but the method remains controversial because of the high cost and of the lack of comparative clinical trials proving the benefit compared to x-rays. Research in applied nuclear physics, including nuclear interactions, dosimetry, image guidance, range verification, novel accelerators and beam delivery technologies, can significantly improve the clinical outcome in particle therapy. Measurements of fragmentation cross-sections, including those for the production of positron-emitting fragments, and attenuation curves are needed for tuning Monte Carlo codes, whose use in clinical environments is rapidly increasing thanks to fast calculation methods. Existing cross sections and codes are indeed not very accurate in the energy and target regions of interest for particle therapy. These measurements are especially urgent for new ions to be used in therapy, such as helium. Furthermore, nuclear physics hardware developments are frequently finding applications in ion therapy due to similar requirements concerning sensors and real-time data processing. In this review we will briefly describe the physics bases, and concentrate on the open issues.

Entities:  

Year:  2016        PMID: 27540827     DOI: 10.1088/0034-4885/79/9/096702

Source DB:  PubMed          Journal:  Rep Prog Phys        ISSN: 0034-4885


  36 in total

1.  Harnessing radiation to improve immunotherapy: better with particles?

Authors:  Marco Durante; Silvia Formenti
Journal:  Br J Radiol       Date:  2019-07-22       Impact factor: 3.039

Review 2.  Cancer Cell Metabolism: Implications for X-ray and Particle Radiation Therapy.

Authors:  Mathieu Sertorio; John P Perentesis; Ralph E Vatner; Anthony E Mascia; Yi Zheng; Susanne I Wells
Journal:  Int J Part Ther       Date:  2018-09-21

Review 3.  Empowering Intensity Modulated Proton Therapy Through Physics and Technology: An Overview.

Authors:  Radhe Mohan; Indra J Das; Clifton C Ling
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-10-01       Impact factor: 7.038

Review 4.  Charged-particle therapy in cancer: clinical uses and future perspectives.

Authors:  Marco Durante; Roberto Orecchia; Jay S Loeffler
Journal:  Nat Rev Clin Oncol       Date:  2017-03-14       Impact factor: 66.675

Review 5.  Particle therapy in non-small cell lung cancer.

Authors:  Zhongxing Liao; Charles B Simone
Journal:  Transl Lung Cancer Res       Date:  2018-04

Review 6.  Particle therapy in the future of precision therapy.

Authors:  Lukas Schaub; Semi Ben Harrabi; Juergen Debus
Journal:  Br J Radiol       Date:  2020-08-14       Impact factor: 3.629

Review 7.  Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies.

Authors:  Sebastian Zahnreich; Heinz Schmidberger
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

8.  Generalized stochastic microdosimetric model: The main formulation.

Authors:  F Cordoni; M Missiaggia; A Attili; S M Welford; E Scifoni; C La Tessa
Journal:  Phys Rev E       Date:  2021-01       Impact factor: 2.529

9.  Monitoring Carbon Ion Beams Transverse Position Detecting Charged Secondary Fragments: Results From Patient Treatment Performed at CNAO.

Authors:  Marco Toppi; Guido Baroni; Giuseppe Battistoni; Maria Giuseppina Bisogni; Piergiorgio Cerello; Mario Ciocca; Patrizia De Maria; Micol De Simoni; Marco Donetti; Yunsheng Dong; Alessia Embriaco; Veronica Ferrero; Elisa Fiorina; Marta Fischetti; Gaia Franciosini; Aafke Christine Kraan; Carmela Luongo; Etesam Malekzadeh; Marco Magi; Carlo Mancini-Terracciano; Michela Marafini; Ilaria Mattei; Enrico Mazzoni; Riccardo Mirabelli; Alfredo Mirandola; Matteo Morrocchi; Silvia Muraro; Vincenzo Patera; Francesco Pennazio; Angelo Schiavi; Adalberto Sciubba; Elena Solfaroli-Camillocci; Giancarlo Sportelli; Sara Tampellini; Giacomo Traini; Serena Marta Valle; Barbara Vischioni; Viviana Vitolo; Alessio Sarti
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

Review 10.  Small-molecule drug repurposing to target DNA damage repair and response pathways.

Authors:  Jacqueline A Brinkman; Yue Liu; Stephen J Kron
Journal:  Semin Cancer Biol       Date:  2020-02-27       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.